TL;DR — 5 Key Findings
- Coffee brands raised an avg 6.2% in Q2 — the steepest pricing move in the category in two years, driven by arabica supply shortages and a wave of premiumization repositioning (Death Wish → Blue Bottle tier).
- Skincare cut promo depth by 12% — the category's aggressive 2024–2025 discounting experiment is over. Brands are pulling back discount floors and testing "subscription-gated" offers instead of straight %-off.
- 3 supplement brands undercut category leaders by >$8 on comparable-stack products — an arbitrage window drawing new entrants into the greens/nootropics subcategory.
- Apparel CPI +10.9% is real, but hitting brands differently — brands that locked in nearshored (Mexico/Central America) manufacturing in 2024 are insulated; those still on Asian supply chains are absorbing 15–22% cost increases with no pricing power to match.
- Jewelry brands face a gold price crisis (up 162% in 5 years) but are splitting into two strategies: premiumization toward fine jewelry or pivoting to silver/stainless as the new "accessible luxe" floor.
Methodology
What we track: 50 DTC brands across Coffee, Skincare, Supplements, Apparel, and Jewelry — scraped weekly from direct-to-consumer checkout pages.
Why weekly: DTC pricing is now a daily decision. Creator campaigns, competitor moves, and inventory shifts can change effective prices within hours. Monthly snapshots miss the signal.
Scope:
- 50 brands, weekly scrapes
- 5 verticals: Coffee (8 brands), Skincare (12 brands), Supplements (12 brands), Apparel (10 brands), Jewelry (8 brands)
- Q2 2026 = April 1 – June 30, 2026
- Metrics tracked: base price, effective price (with any applied discount), subscription price, promo depth (% off MSRP), bundle pricing
All prices are verified at checkout. "Promo depth" is measured as the gap between MSRP and the lowest available effective price at any point in the quarter. Pricing excludes shipping.
Coffee — The 6.2% Price Hike Nobody Saw Coming
Coffee had the most aggressive pricing action of any vertical in Q2. The average MSRP increase across our 8 tracked brands hit +6.2%, driven by two compounding pressures:
- Arabica supply constraints — Brazil's 2025–2026 arabica harvest underperformed due to drought and biennial cycle effects, tightening the green coffee market. Futures for arabica contracts rose ~18% from January to April 2026.
- Premiumization repositioning — A cluster of mid-tier brands repositioned upward into the specialty tier, raising price floors to compete with Blue Bottle and Intelligentsia rather than Death Wish.
Biggest Mover: Chamberlain Coffee (+14.3%)
Emma Chamberlain's brand executed the sharpest single move in the category, raising prices 14.3% across its single-origin subscription tiers in May 2026. The brand simultaneously opened its second brick-and-mortar café on Venice Beach's Abbot Kinney — a clear signal of a lifestyle brand moving upmarket post-Series stage.
Chamberlain Coffee is now priced at parity with mid-tier specialty roasters (~$18–$22/bag subscription), a significant gap from its early DTC positioning as an "accessible influencer brand."
Subscription churn is stabilizing. Coffee subscription churn averaged 4–7% monthly in Q2 — tight with supplements (5–8%) but meaningfully lower than the peak pandemic era. The key driver: brands that layered in personalization (grind preference, roast profile quiz, frequency controls) see 20–30% lower first-month churn than flat replenishment-only offers.
If you're in coffee:
The window to compete on price alone is closed. The brands winning in Q2 are winning on experience (personalization, café integration, origin storytelling), not on bag price. Lock in your green coffee sourcing now — input cost inflation in Q3 is likely to continue.
Try Stratify's Price Gap Tool →Skincare — The End of Aggressive Discounting
Skincare's 2024–2025 experiment with heavy discounting (BOGO, 40%+ off sitewide sales) is over. In Q2, the category pulled back meaningfully:
- Promo depth fell 12% quarter-over-quarter (from an average 28% effective discount in Q1 to ~24% in Q2)
- Founder-led content offers replaced %-off offers — brands shifted discount budgets into creator partnerships and UGC content, which carry a 12–18% lower CPA premium
- Subscription-first pricing is emerging as the new acquisition hook: rather than discounting a one-time purchase, brands offer 15–20% off when you subscribe — and that subscription is the discount mechanism
Biggest Mover: The Inkey List (+9.1%)
The Inkey List raised prices on its hero products (Barrier Restore Serum, Succinic Acid) by 9.1% in Q2, betting on clinical formulation as a price-justification signal. This follows a pattern across accessible skincare: the "affordable clinical" positioning is moving upmarket.
"Lipstick Effect" hits skincare positively. Consumer behavior in Q2 shows a bifurcated pattern — "affordable indulgences" are growing. Skincare and beauty brands at the $15–$45 price point are outperforming mass-market and ultra-premium in equal measure. Brands like e.l.f. and The Inkey List are capturing both the "treat myself" mindset and the "scientific skincare on a budget" buyer.
If you're in skincare:
Stop buying customers with discounts. The brands winning on acquisition are using subscription mechanics and content partnerships instead of %-off sitewide sales. Your discount floor should be a subscription offer, not a clearance signal.
See skincare pricing trends →Supplements — The $8 Arbitrage Window
Three brands in our tracker — Everyday Dose, a new entrant in the nootropics subcategory, and a verified greens brand — are priced $8–$14 below comparable stacks from AG1, Mindbody, and Rootine on a per-month basis.
The gap isn't from lower quality: it's from lower ad spend as % of revenue (leaner CAC), powder-based vs. capsule-formatted (different cost structure), and subscription-only model (no retail inventory overhead).
Biggest Mover: Everyday Dose (Mushroom Coffee)
Everyday Dose is a case study in DTC pricing arbitrage. The brand built a 9-figure revenue business by serving customers who want the AG1 stack but at a lower price point — and delivering a genuinely different product (mushroom coffee vs. greens powder). Subscription LTV runs $300–$600 for standard vitamin stacks; premium greens (AG1 tier) runs $600–$1,200.
Telehealth hybrids are expanding into "Affordable Clinical." Hims & Hers (2.2M subscribers, 79% gross margin, 85% retention) and Ro's telehealth-supplement hybrids are expanding their stack offerings. In Q2, both brands added foundational supplements (multivitamin, Omega-3) to their bundles at $25–$35/month — directly competing with the DTC-only supplement brands.
If you're in supplements:
Your defensible moat is product differentiation — not price. The arbitrage window is closing as telehealth brands enter with lower CAC and more clinical credibility. Find your "everyday dose" angle or move upmarket to clinical premium.
See supplement pricing trends →Apparel — Who's Insulated, Who's Bleeding
Apparel CPI is up +10.9% YoY, consumer sentiment is at 53.3 (depressed), and the saving rate dropped to 3.6%. But the brands in our tracker are navigating this very differently:
| Brand group | Supply chain | Margin exposure |
|---|---|---|
| Vuori, Cuts Clothing | Nearshored (Mexico/CA, locked 2024) | ~20–25% below current Asia rates |
| Exposed brands | Still on Asian supply chains | +15–22% cost increases, no pricing power |
Biggest Mover: Everlane (Transparency Pricing Model)
Everlane continues to set the floor on transparency pricing — and it's working. Their 3.5% conversion rate (vs. 2.2% apparel industry average) proves that showing real costs builds purchase confidence. Brands that share cost breakdowns see lower return rates and higher AOV.
Subscription apparel is dead. Long live replenishment. Subscription box apparel (Stitch Fix, etc.) is declining, but replenishment basics (restock tees, underwear, socks) are growing. The playbook: simple flat pricing, no curation algorithm, just "sign up for your basics." Everlane, Pact, and several smaller brands are quietly building solid base subscription revenue on this model.
If you're in apparel:
Nearshoring was the right call. If you haven't locked in manufacturing in the Western Hemisphere, do it now — 2027 tariff cycles will make Asian imports increasingly uneconomical. Also: shift your discount budget from promotional sales to membership/subscription economics.
See apparel pricing trends →Jewelry — Gold at $5,000/oz and a Market Splitting in Two
Gold crossed $5,000/oz in Q1 2026 — a 162% increase over 5 years. Sterling silver went from $32/oz to ~$75/oz. This is the most significant commodity shock for DTC jewelry in a decade.
The market is splitting into two distinct strategies:
- Strategy A: Go Premium Fine — move upmarket into 14k–18k solid gold, diamond, and gemstone pieces. Brands like Mejuri and Aurate New York are raising their floor (now $150–$300 entry points) and leaning into investment/heirloom positioning. Gross margins healthy at ~60–70% even with higher metal costs.
- Strategy B: Pivot to Accessible Demi-Fine — brands like Ana Luisa, Quince, and GLDN are expanding their sterling silver and gold vermeil lines, leaning into the "luxe for $50–$150" positioning.
Biggest Mover: Mejuri (Weekly Price Adjustments)
Toronto-based Mejuri has been adjusting prices weekly to manage gold cost exposure. Their 14k gold pieces are now up ~8% YoY. The brand's strategy of "always new, always dropping" keeps customers engaged and less price-sensitive on any single piece.
Lab-grown diamond brands growing fast — but watch the economics. Dorsey (+50%), Clean Origin (+83%), Atolea (+49%) — the second-wave lab-grown diamond brands are growing. But wholesale lab-grown prices dropped 42% YoY through mid-2025. Gross margins on lab-grown look healthy (~74%), but in dollar terms you need to move ~4 lab-grown stones to match the profit from 1 comparable natural sale. Brands are carrying lab-grown to capture searches, not necessarily for margin.
If you're in jewelry:
Pick a lane and commit. The middle is getting squeezed. Either go upmarket with solid gold/diamonds and justify pricing on craftsmanship and investment value, or go accessible with silver/vermeil and compete on design and accessibility. Hedging between the two is a margin trap.
See jewelry pricing trends →